Turn Therapeutics Statistics

Total Valuation

TTRX has a market cap or net worth of $142.26 million. The enterprise value is $136.56 million.

Market Cap	142.26M
Enterprise Value	136.56M

Important Dates

The next estimated earnings date is Wednesday, May 13, 2026.

Earnings Date	May 13, 2026
Ex-Dividend Date	n/a

Share Statistics

TTRX has 29.45 million shares outstanding. The number of shares has increased by 3.81% in one year.

Current Share Class	29.45M
Shares Outstanding	29.45M
Shares Change (YoY)	+3.81%
Shares Change (QoQ)	+1.77%
Owned by Insiders (%)	59.47%
Owned by Institutions (%)	0.30%
Float	10.49M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	263.54
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.43, with a Debt / Equity ratio of 0.18.

Current Ratio	1.43
Quick Ratio	1.35
Debt / Equity	0.18
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-200.87%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	3.73
200-Day Moving Average	n/a
Relative Strength Index (RSI)	60.97
Average Volume (20 Days)	70,038

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-3.99M
Pretax Income	-3.80M
Net Income	-3.80M
EBITDA	-3.94M
EBIT	-3.99M
Earnings Per Share (EPS)	-$0.14

Full Income Statement

Balance Sheet

The company has $3.11 million in cash and $91,173 in debt, with a net cash position of $3.01 million or $0.10 per share.

Cash & Cash Equivalents	3.11M
Total Debt	91,173
Net Cash	3.01M
Net Cash Per Share	$0.10
Equity (Book Value)	504,019
Book Value Per Share	0.02
Working Capital	985,486

Full Balance Sheet

Cash Flow

Operating Cash Flow	-1.82M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TTRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.81%
Shareholder Yield	-3.81%
Earnings Yield	-2.72%
FCF Yield	n/a

Analyst Forecast

The average price target for TTRX is $8.00, which is 65.59% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.00
Price Target Difference	65.59%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1